SONOVASCULAR
SonoVascular is a medical technology company that develops a multi-mechanistic thrombectomy system for the treatment of arterial and venous diseases, including deep vein thrombosis, pulmonary embolism, peripheral artery occlusion, and acute ischemic stroke.
SONOVASCULAR
Social Links:
Industry:
Health Care Medical Device Wellness
Founded:
2018-01-01
Address:
Chapel Hill, North Carolina, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
750 K USD
Similar Organizations
metaMe Health
MetaMe Health develops FDA-cleared prescription digital therapeutics for the treatment of gastrointestinal conditions.
Waypoint Orthopedics
Waypoint Orthopedics makes vertebral fixation safer and more efficient for patients, surgeons, and support staff.
Current Employees Featured
Founder
More informations about "SonoVascular"
SonoVascular
SonoVascular Enters into Strategic Collaboration with Lantheus Holdings, Inc. for Use of Microbubbles in Combination with SonoThrombectomy System for Treatment of Venous Thromboembolism. READ MORE. Novel Microbubble …See details»
SonoVascular - Crunchbase Company Profile & Funding
Organization. SonoVascular . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... SonoVascular is a medical technology company that develops a multi …See details»
SonoVascular, Inc. - LinkedIn
101 Glen Lennox Dr Suite 250 Chapel Hill, North Carolina 27517, USSee details»
Sonovascular Company Profile 2024: Valuation, Funding
What industry is Sonovascular in? Sonovascular’s primary industry is Surgical Devices. Is Sonovascular a private or public company? Sonovascular is a Private company. What is …See details»
WIN Backs SonoVascular Ahead of Clinical Trials
Jul 5, 2023 The Wolfpack Investor Network (WIN) announced its newest investment in SonoVascular, an early-stage medical device company that offers a novel approach for the treatment of pulmonary embolism and deep vein …See details»
SonoVascular Enters into Strategic Collaboration with …
May 2, 2024 SonoVascular, Inc. Daniel Estay Founder and Chief Executive Officer [email protected] 1 Gregson J, Kaptoge S, Bolton T, et al. Cardiovascular Risk Factors Associated With Venous Thromboembolism.See details»
UNC spin-out aims for $10M+ raise to support new …
Jul 14, 2023 The startup is beginning to transition from a preclinical company to a clinical-stage organization. SonoVascular is aiming to raise more than $10 million for a Series A round in the fourth quarter ...See details»
SonoVascular Initiates FIH Study for Ultrasound-Facilitated ...
August 27, 2024—SonoVascular, Inc. announced the start of a first-in-human (FIH) study for its SonoThrombectomy System. The company describes the SonoVascular platform as an …See details»
WIN and Harbright Raise Over $1.75M for SonoVascular
Oct 29, 2024 FOR IMMEDIATE RELEASE. Raleigh, NC – October 29, 2024 – The Wolfpack Investor Network (WIN) and Harbright Ventures are excited to announce a follow-on …See details»
SonoVascular - Funding, Financials, Valuation & Investors
SonoVascular develops a multi-mechanistic thrombectomy system for the treatment of arterial and venous diseases. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much …See details»
Chapel Hill-based SonoVascular developing new hybrid …
May 16, 2024 They currently serve as SonoVascular technical advisors. Estay, who has spent much of his decades-long career in the cardiovascular medical devices industry, initially read about the research in 2017 while reviewing a …See details»
Revolutionizing VTE Treatment: SonoThrombectomy™ Trial in …
Sep 6, 2024 SonoVascular designs and develops innovative therapeutic ultrasound-based medical devices for treating vascular disease. Founded in 2018, SonoVascular developed the …See details»
SonoVascular Announces Successful Treatment of First Patient …
Aug 27, 2024 SonoVascular, Inc., a private medical device company, has announced the successful initiation of its first human study with its SonoThrombectomyä System. The …See details»
SonoVascular Announces Successful Treatment of First Patient
CHAPEL HILL, N.C., Aug. 27, 2024 /PRNewswire/ -- SonoVascular, Inc., a private medical device company, has announced the successful initiation of its first human study with its …See details»
Early-stage medical device company gets boost from Wolfpack …
Jul 12, 2023 RALEIGH – The Wolfpack Investor Network announced its newest investment in SonoVascular, an early-stage medical device company that offers a novel approach for the …See details»
SonoVascular Announces Successful Treatment of First Patient …
CHAPEL HILL, N.C., Aug. 27, 2024 /PRNewswire/ -- SonoVascular, Inc., a private medical device company, has announced the successful initiation of its first human study with its …See details»
SonoVascular - Contacts, Employees, Board Members, Advisors
SonoVascular develops a multi-mechanistic thrombectomy system for the treatment of arterial and venous diseases.See details»
SonoVascular: Versatility in a Single Thrombectomy Platform
Dec 19, 2023 SonoVascular is developing a venous thrombectomy platform that offers versatility in a single platform that’s a total solution for DVT and PE. In operating by multiple modalities …See details»
First-in-human study of SonoThrombectomy system completed
Aug 27, 2024 The SonoThrombectomy system catheter. SonoVascular has announced the successful initiation of its first-in-human study (FIH) of the company’s SonoThrombectomy …See details»
SonoVascular Announces Successful Treatment of First Patient …
CHAPEL HILL, N.C., Aug. 27, 2024 /PRNewswire/ -- SonoVascular, Inc., a private medical device company, has announced the successful initiation of its first human study with its …See details»